VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VYNE VYNE Therapeutics Inc.

交易中 11-22 13:55:35 EST

3.08

+0.18

+6.21%

最高3.12	最低2.88	成交量3.76万
今开2.88	昨收2.90	日振幅8.28%
总市值4,543万	流通市值3,109万	总股本1,475万
成交额11.28万	换手率0.37%	流通股本1,010万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VYNE","market":"US","secType":"STK","nameCN":"VYNE Therapeutics Inc.","latestPrice":3.08,"timestamp":1732301702887,"preClose":2.9,"halted":0,"volume":37585,"delay":0,"floatShares":10095478,"shares":14751433,"eps":-0.858797,"marketStatus":"交易中","marketStatusCode":2,"change":0.18,"latestTime":"11-22 13:55:35 EST","open":2.88,"high":3.12,"low":2.88,"amount":112807.7806155,"amplitude":0.082759,"askPrice":3.11,"askSize":167,"bidPrice":3.07,"bidSize":80,"shortable":3,"etf":0,"ttmEps":-0.858797,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1516856400000,"adjPreClose":2.9,"postHourTrading":{"tag":"盘后","latestPrice":2.9,"preClose":2.9,"latestTime":"19:51 EST","volume":203,"amount":588.34,"timestamp":1732236680132},"volumeRatio":0.743596,"impliedVol":3.8705,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/VYNE/wiki","defaultTab":"wiki","newsList":[{"id":"2485141068","title":"Vyne Therapeutics Inc.盘中异动 快速拉升5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485141068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485141068?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:27","pubTimestamp":1732120038,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时27分，Vyne Therapeutics Inc.股票出现异动，股价急速上涨5.86%。截至发稿，该股报2.89美元/股，成交量3.4354万股，换手率0.23%，振幅3.98%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112100271898e43c6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112100271898e43c6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VYNE","BK4139","BK4007"],"gpt_icon":0},{"id":"2484967568","title":"Vyne Therapeutics Inc.盘中异动 早盘股价大涨5.19%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484967568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484967568?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940283,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分，Vyne Therapeutics Inc.股票出现异动，股价大幅上涨5.19%。截至发稿，该股报2.84美元/股，成交量2329股，换手率0.02%，振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822312395be481f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822312395be481f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","VYNE"],"gpt_icon":0},{"id":"2483309815","title":"Vyne Therapeutics Inc.2024财年第三财季实现净利润-12.16百万美元，同比减少100.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483309815?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686437,"startTime":"0","endTime":"0","summary":"11月16日，Vyne Therapeutics Inc.公布财报，公告显示公司2024财年第三财季净利润为-12.16百万美元，同比减少100.33%；其中营业收入为121000.00美元，同比增加6.14%，每股基本收益为-0.29美元。从资产负债表来看，Vyne Therapeutics Inc.总负债12.66百万美元，其中短期债务123000.00美元，资产负债比为6.02，流动比率为5.81。机构评级：截至2024年11月16日，当前有3家机构对Vyne Therapeutics Inc.目标价做出预测，其中目标均价为5.58美元，其中最低目标价为5.00美元，最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000345a23b8a11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000345a23b8a11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","LENZ"],"gpt_icon":0},{"id":"2482848180","title":"Vyne Therapeutics Inc  预计每股亏损 25 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482848180","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482848180?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:31","pubTimestamp":1731083500,"startTime":"0","endTime":"0","summary":"Vyne Therapeutics Inc  预计每股亏损 25 美分 - 财报前瞻Vyne Therapeutics Inc VYNE.OQ VYNE.O在公布截至2024年12月31日的财报时，预计季度收入将有所增长。LSEG 分析师对 Vyne Therapeutics Inc 的平均预期是每股亏损 25 美分。华尔街对 Vyne Therapeutics Inc 的 12 个月目标价中位数为 5.75 美元，高于其最新收盘价 3.16 美元。11月8日 - 本摘要于北京时间 11 月 8 日 16:31 机器生成。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF23E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE"],"gpt_icon":0},{"id":"2481318445","title":"Vyne Therapeutics Inc.盘中异动 早盘快速拉升5.11%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481318445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481318445?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:07","pubTimestamp":1730992021,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时07分，Vyne Therapeutics Inc.股票出现异动，股价急速上涨5.11%。截至发稿，该股报3.29美元/股，成交量1.802万股，换手率0.12%，振幅3.83%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723070198e41396&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723070198e41396&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","VYNE"],"gpt_icon":0},{"id":"2480587999","title":"Vyne Therapeutics Inc.盘中异动 快速上涨6.41%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480587999?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:20","pubTimestamp":1730733631,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时20分，Vyne Therapeutics Inc.股票出现异动，股价急速上涨6.41%。截至发稿，该股报2.82美元/股，成交量3.6402万股，换手率0.25%，振幅6.04%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232031ab9ed43d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232031ab9ed43d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VYNE","BK4139","BK4007"],"gpt_icon":0},{"id":"2467977341","title":"Vyne Therapeutics Inc.盘中异动 快速拉升10.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2467977341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467977341?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:37","pubTimestamp":1726234620,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日21时37分，Vyne Therapeutics Inc.股票出现波动，股价快速上涨10.06%。截至发稿，该股报1.97美元/股，成交量383股，换手率0.00%，振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Immuneering Corporation、Syros Pharmaceuticals, Inc.、Instil Bio, Inc.涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为682.69%、69.15%、68.33%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Oramed Pharmaceuticals Inc.、Immuneering Corporation，振幅分别为21.63%、16.10%、16.08%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913213700956323c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913213700956323c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VYNE","BK4007","LENZ"],"gpt_icon":0},{"id":"2460736680","title":"Vyne Therapeutics Inc.2024财年第二财季实现净利润-9.40百万美元，同比增加6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736680","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736680?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910667,"startTime":"0","endTime":"0","summary":"8月18日，Vyne Therapeutics Inc.公布财报，公告显示公司2024财年第二财季净利润为-9.40百万美元，同比增加6.37%；其中营业收入为198000.00美元，同比增加46.67%，每股基本收益为-0.22美元。从资产负债表来看，Vyne Therapeutics Inc.总负债11.78百万美元，其中短期债务120000.00美元，资产负债比为7.36，流动比率为7.14。机构评级：截至2024年8月18日，当前有3家机构对Vyne Therapeutics Inc.目标价做出预测，其中目标均价为5.58美元，其中最低目标价为5.00美元，最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006559f3407c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006559f3407c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","LENZ"],"gpt_icon":0},{"id":"2458512036","title":"Vyne Therapeutics Inc    预计每股亏损 19 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458512036","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458512036?lang=zh_cn&edition=full","pubTime":"2024-08-10 02:07","pubTimestamp":1723226833,"startTime":"0","endTime":"0","summary":"   * Vyne Therapeutics Inc    预计将在8月12日公布截至2024年6月30日的业绩() 时显示季度收入下降   * 根据LSEG的数据，一位分析师预计，这家总部位于新泽西州布里奇沃特的公司的营收将从去年同期的13.5万美元下降至11万美元，降幅为18.5%。* LSEG 分析师对 Vyne Therapeutics Inc 的平均预期是每股亏损 19 美分。* 华尔街对 Vyne Therapeutics Inc 的 12 个月目标价中位数为 5.75 美元，高于其上一次收盘价 1.77 美元。8月9日 - 本摘要于北京时间 8 月 9 日 18:07 机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","VYNE"],"gpt_icon":0},{"id":"2456284605","title":"Vyne Therapeutics Inc.盘中异动 早盘大幅跳水5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456284605","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456284605?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:49","pubTimestamp":1722606556,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时49分，Vyne Therapeutics Inc.股票出现异动，股价大幅下跌5.77%。截至发稿，该股报1.72美元/股，成交量1.0435万股，换手率0.07%，振幅2.75%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.90%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Dermata Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1314.92%、505.64%、41.43%，振幅较大的相关个股有Os Therapies Incorporated、Exicure, Inc.、Dermata Therapeutics, Inc.，振幅分别为54.19%、49.18%、37.50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802214916af95a700&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802214916af95a700&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2453572795","title":"Vyne Therapeutics Inc.盘中异动 早盘股价大跌5.16%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453572795","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453572795?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:59","pubTimestamp":1721656759,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时59分，Vyne Therapeutics Inc.股票出现波动，股价快速下跌5.16%。截至发稿，该股报2.02美元/股，成交量2324股，换手率0.02%，振幅3.85%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222159209681ee79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222159209681ee79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","VYNE","LENZ"],"gpt_icon":0},{"id":"2446902841","title":"Vyne Therapeutics Inc.盘中异动 早盘快速上涨6.36%报1.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446902841","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446902841?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:31","pubTimestamp":1719322275,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时31分，Vyne Therapeutics Inc.股票出现异动，股价大幅上涨6.36%。截至发稿，该股报1.84美元/股，成交量3883股，换手率0.03%，振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大，Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为84.65%、77.75%、56.52%，振幅较大的相关个股有Glycomimetics, Inc.、Lipella Pharmaceuticals Inc.、Senti Biosciences, Inc.，振幅分别为12.94%、12.48%、7.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406252131159f640dda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406252131159f640dda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VYNE","BK4139","LENZ"],"gpt_icon":0},{"id":"2441208604","title":"HC Wainwright &amp; Co.：重申VYNE Therapeutics(VYNE.US)评级，由买入调整至买入评级, 目标价由5.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441208604","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441208604?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:20","pubTimestamp":1717600853,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","VYNE","BK4007","BK4139"],"gpt_icon":0},{"id":"2439045115","title":"Vyne Therapeutics Inc.盘中异动 快速下跌5.80%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439045115","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439045115?lang=zh_cn&edition=full","pubTime":"2024-05-30 02:30","pubTimestamp":1717007424,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日02时30分，Vyne Therapeutics Inc.股票出现异动，股价大幅跳水5.80%。截至发稿，该股报2.44美元/股，成交量5.5954万股，换手率0.39%，振幅5.21%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530023024aef25a99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530023024aef25a99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","VYNE","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vynetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.2083},{"period":"3month","weight":0.5508},{"period":"6month","weight":0.124},{"period":"1year","weight":-0.2564},{"period":"ytd","weight":0.2446}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"VYNE Therapeutics Inc.成立于2011年10月，是特拉华州的一家公司，名称为Tigercat Pharma，Inc.。该公司是一家专业制药公司，致力于开发和商业化专有疗法，以满足皮肤病学未满足的需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.103241},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.000108},{"month":3,"riseRate":0.428571,"avgChangeRate":0.048397},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.184881},{"month":5,"riseRate":0.571429,"avgChangeRate":0.038029},{"month":6,"riseRate":0,"avgChangeRate":-0.163623},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.064684},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.080327},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.032924},{"month":10,"riseRate":0.428571,"avgChangeRate":0.003758},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.048728},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.145707}],"exchange":"NASDAQ","name":"VYNE Therapeutics Inc.","nameEN":"VYNE Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VYNE Therapeutics Inc.(VYNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VYNE Therapeutics Inc.,VYNE,VYNE Therapeutics Inc.股票,VYNE Therapeutics Inc.股票老虎,VYNE Therapeutics Inc.股票老虎国际,VYNE Therapeutics Inc.行情,VYNE Therapeutics Inc.股票行情,VYNE Therapeutics Inc.股价,VYNE Therapeutics Inc.股市,VYNE Therapeutics Inc.股票价格,VYNE Therapeutics Inc.股票交易,VYNE Therapeutics Inc.股票购买,VYNE Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VYNE Therapeutics Inc.(VYNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}